{
    "organizations": [],
    "uuid": "91db38072d6ed08b48dec5837edb7924ed8e8c92",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-prometic-granted-orphan-drug-desig/brief-prometic-granted-orphan-drug-designation-by-fda-idUSASB0C5ZJ",
    "ord_in_thread": 0,
    "title": "BRIEF-Prometic Granted Orphan Drug Designation By FDA",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 15 (Reuters) - Prometic Life Sciences Inc:\n* PROMETIC GRANTED ORPHAN DRUG DESIGNATION BY FDA FOR INTER-ALPHA-INHIBITOR-PROTEINS FOR TREATMENT OF NECROTIZING ENTEROCOLITIS (NEC)\n* PROMETIC LIFE SCIENCES INC - ORPHAN DRUG DESIGNATION STATUS HAS BEEN GRANTED TO ITS IAIP FOR TREATMENT OF NECROTIZING ENTEROCOLITIS BY U.S. FDA Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-15T22:18:00.000+02:00",
    "crawled": "2018-02-16T16:45:30.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "prometic",
        "life",
        "science",
        "inc",
        "prometic",
        "granted",
        "orphan",
        "drug",
        "designation",
        "fda",
        "treatment",
        "necrotizing",
        "enterocolitis",
        "nec",
        "prometic",
        "life",
        "science",
        "inc",
        "orphan",
        "drug",
        "designation",
        "status",
        "granted",
        "iaip",
        "treatment",
        "necrotizing",
        "enterocolitis",
        "fda",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}